KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $143,592,000 | +83.4% | 798,569 | +5.8% | 0.07% | +72.5% |
| Q2 2017 | $78,276,000 | +8.7% | 755,069 | -17.7% | 0.04% | +2.6% |
| Q1 2017 | $72,039,000 | +120.4% | 917,818 | +25.9% | 0.04% | +116.7% |
| Q4 2016 | $32,690,000 | -9.5% | 729,040 | +12.8% | 0.02% | -10.0% |
| Q3 2016 | $36,108,000 | +331.9% | 646,391 | +286.6% | 0.02% | +300.0% |
| Q2 2016 | $8,360,000 | -3.6% | 167,206 | -11.5% | 0.01% | 0.0% |
| Q1 2016 | $8,672,000 | -24.9% | 188,897 | +0.8% | 0.01% | -37.5% |
| Q4 2015 | $11,548,000 | +2286.0% | 187,406 | +2056.8% | 0.01% | – |
| Q3 2015 | $484,000 | -45.2% | 8,689 | -40.1% | 0.00% | -100.0% |
| Q2 2015 | $884,000 | +163.1% | 14,500 | +148.9% | 0.00% | – |
| Q1 2015 | $336,000 | -61.1% | 5,825 | -61.1% | 0.00% | -100.0% |
| Q4 2014 | $864,000 | +5.2% | 14,991 | -47.9% | 0.00% | 0.0% |
| Q3 2014 | $821,000 | – | 28,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $108,260,000 | 37.66% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,479,000 | 8.02% |
| RTW INVESTMENTS, LP | 343,503 | $15,770,000 | 5.72% |
| DSAM Partners (London) Ltd | 256,550 | $11,778,000 | 5.26% |
| Silver Rock Financial LLC | 109,199 | $5,013,000 | 5.09% |
| Casdin Capital, LLC | 75,000 | $3,443,000 | 3.95% |
| EcoR1 Capital, LLC | 150,000 | $6,887,000 | 2.41% |
| Vivo Capital, LLC | 193,193 | $8,869,000 | 2.22% |
| BB BIOTECH AG | 750,000 | $34,433,000 | 1.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 494,988 | $22,725,000 | 1.36% |